ArticleMultiple sclerosis journal - experimental, translational and clinical

Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine.

Sarah Conway et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.